Industry
Biotechnology
Quoin Pharmaceuticals, Ltd., a specialty pharmaceutical company, focuses on the development of therapeutic products for rare and orphan diseases. The company's lead product is QRX003, a topical lotion to treat Netherton Syndrome. It also develops QRX004 for the treatment dystrophic epidermolysis bullosa; and QRX006, a therapy to treat rare skin disease. The company is based in Ashburn, Virginia.
Loading...
Open
N/A
Mkt cap
N/A
Volume
N/A
High
N/A
P/E Ratio
N/A
52-wk high
N/A
Low
N/A
Div yield
N/A
52-wk low
N/A
Portfolio Pulse from Benzinga Newsdesk
March 15, 2024 | 3:15 pm
Portfolio Pulse from Benzinga Insights
March 13, 2024 | 8:15 pm
Portfolio Pulse from Benzinga Newsdesk
March 13, 2024 | 8:13 pm
Portfolio Pulse from Benzinga Insights
March 13, 2024 | 10:15 am
Portfolio Pulse from Benzinga Insights
March 12, 2024 | 5:01 pm
Portfolio Pulse from Benzinga Insights
March 08, 2024 | 1:09 pm
Portfolio Pulse from Avi Kapoor
March 05, 2024 | 6:11 pm
Portfolio Pulse from Benzinga Insights
March 05, 2024 | 5:33 pm
Portfolio Pulse from Henry Khederian
March 05, 2024 | 3:38 pm
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.